Post Carotid Stenting Cerebral Hyperperfusion: a Preventable Complication

This syndrome, which can be reverted, is also one of the causes of preventable stroke, at least in the context of carotid endarterectomy. At present, there is little information on the incidence of this condition in the context of carotid stenting, which is the purpose of this study, in addition to providing tips to prevent it.

Síndrome de Hiperperfusión cerebral post-angioplastia carotídea: una complicación prevenibleA systematic search resulted in 33 studies with a total 8731 carotid stenting procedures reporting 4.6% hyperperfusion risk (3.1 to 6.8%). Nearly half of hyperperfusion patients later had a stroke (47%), and more than half of strokes resulted fatal or disabling (54%).

 

Symptoms did not appear immediately after procedure, but at average 12 hours after procedure (8 to 36 hour range). This is clearly different form embolic stroke, also diagnosed in the same cath lab.


Read also: Far from a Being a Pun, Malnutrition Tips the Scales in TAVR.


Impaired cerebrovascular reserve was associated to higher risk of post stenting hyperperfusion syndrome (RR 5.18; CI 95% 1.0 to 26.8; p=0.049).

 

If the procedure takes place in the context of a symptomatic patient, the risk of periprocedural stroke is a lot higher ─this we have known for some time now. What we did not know is that evolution with hyperperfusion syndrome involves significantly lower risk of stroke compared to acute patients (RR 0.20; IC 95% 0.07 to 0.59; p=0.001).


Read also: Cost-Effectiveness of Frenestrated or Branched Endoprostheses vs. Open Surgery.


Patients with bilateral carotid stenosis or very critical lesions should be watched closely in the first hours after procedure, and their blood pressure needs to be monitored obsessively.

 

Conclusion

Cerebral hyperperfusion syndrome is relatively frequent and serious in patients undergoing carotid stenting, and it appears in the first hours after procedure, never immediately. We should encourage further research to find out how to treat this phenomenon, and also how to control blood pressure and measure cerebral blood flow.

 

Original title: Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysis.

Reference: Anne E. Huibers et al. Eur J Vasc Endovasc Surg (2018). Article in press.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....